These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24282282)

  • 1. Identification of a cyclin D1 network in prostate cancer that antagonizes epithelial-mesenchymal restraint.
    Ju X; Casimiro MC; Gormley M; Meng H; Jiao X; Katiyar S; Crosariol M; Chen K; Wang M; Quong AA; Lisanti MP; Ertel A; Pestell RG
    Cancer Res; 2014 Jan; 74(2):508-19. PubMed ID: 24282282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TMPRSS4 induces invasion and proliferation of prostate cancer cells through induction of Slug and cyclin D1.
    Lee Y; Ko D; Min HJ; Kim SB; Ahn HM; Lee Y; Kim S
    Oncotarget; 2016 Aug; 7(31):50315-50332. PubMed ID: 27385093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression.
    Ding Z; Wu CJ; Chu GC; Xiao Y; Ho D; Zhang J; Perry SR; Labrot ES; Wu X; Lis R; Hoshida Y; Hiller D; Hu B; Jiang S; Zheng H; Stegh AH; Scott KL; Signoretti S; Bardeesy N; Wang YA; Hill DE; Golub TR; Stampfer MJ; Wong WH; Loda M; Mucci L; Chin L; DePinho RA
    Nature; 2011 Feb; 470(7333):269-73. PubMed ID: 21289624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
    Jin Y; Cui Z; Li X; Jin X; Peng J
    Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma.
    Xu S; Yi XM; Tang CP; Ge JP; Zhang ZY; Zhou WQ
    Oncol Rep; 2016 Jul; 36(1):10-22. PubMed ID: 27176634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
    Wu Z; He B; He J; Mao X
    Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ErbB-2 induces the cyclin D1 gene in prostate epithelial cells in vitro and in vivo.
    Casimiro M; Rodriguez O; Pootrakul L; Aventian M; Lushina N; Cromelin C; Ferzli G; Johnson K; Fricke S; Diba F; Kallakury B; Ohanyerenwa C; Chen M; Ostrowski M; Hung MC; Rabbani SA; Datar R; Cote R; Pestell R; Albanese C
    Cancer Res; 2007 May; 67(9):4364-72. PubMed ID: 17483350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notch promotes tumor metastasis in a prostate-specific Pten-null mouse model.
    Kwon OJ; Zhang L; Wang J; Su Q; Feng Q; Zhang XH; Mani SA; Paulter R; Creighton CJ; Ittmann MM; Xin L
    J Clin Invest; 2016 Jul; 126(7):2626-41. PubMed ID: 27294523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A reduction in Pten tumor suppressor activity promotes ErbB-2-induced mouse prostate adenocarcinoma formation through the activation of signaling cascades downstream of PDK1.
    Rodriguez OC; Lai EW; Vissapragada S; Cromelin C; Avetian M; Salinas P; Ramos H; Kallakury B; Casimiro M; Lisanti MP; Tanowitz HB; Pacak K; Glazer RI; Avantaggiati M; Albanese C
    Am J Pathol; 2009 Jun; 174(6):2051-60. PubMed ID: 19443706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin D1, Id1 and EMT in breast cancer.
    Tobin NP; Sims AH; Lundgren KL; Lehn S; Landberg G
    BMC Cancer; 2011 Sep; 11():417. PubMed ID: 21955753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-specific consequences of cyclin D1 overexpression in prostate cancer progression.
    He Y; Franco OE; Jiang M; Williams K; Love HD; Coleman IM; Nelson PS; Hayward SW
    Cancer Res; 2007 Sep; 67(17):8188-97. PubMed ID: 17804732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer.
    Cao Z; Shi X; Tian F; Fang Y; Wu JB; Mrdenovic S; Nian X; Ji J; Xu H; Kong C; Xu Y; Chen X; Huang Y; Wei X; Yu Y; Yang B; Chung LWK; Wang F
    Cell Death Dis; 2021 Jan; 12(1):2. PubMed ID: 33414463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin D1 antagonizes BRCA1 repression of estrogen receptor alpha activity.
    Wang C; Fan S; Li Z; Fu M; Rao M; Ma Y; Lisanti MP; Albanese C; Katzenellenbogen BS; Kushner PJ; Weber B; Rosen EM; Pestell RG
    Cancer Res; 2005 Aug; 65(15):6557-67. PubMed ID: 16061635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of Akt signaling in prostate induces a TGFβ-mediated restraint on cancer progression and metastasis.
    Bjerke GA; Yang CS; Frierson HF; Paschal BM; Wotton D
    Oncogene; 2014 Jul; 33(28):3660-7. PubMed ID: 23995785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of adenovirus-mediated PTEN on the proliferation of prostate cancer PC-3 cells and expressions of cyclin D1 and p21].
    Gao L; Pan TJ; Wu GJ; Shen GQ; Yang JR; Wen HD; Xie S; Qian WH
    Zhonghua Nan Ke Xue; 2014 Mar; 20(3):207-12. PubMed ID: 24738455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The steroid receptor coactivator-3 is required for the development of castration-resistant prostate cancer.
    Tien JC; Liu Z; Liao L; Wang F; Xu Y; Wu YL; Zhou N; Ittmann M; Xu J
    Cancer Res; 2013 Jul; 73(13):3997-4008. PubMed ID: 23650284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Splice Variant of the Inhibitor of Growth 3 Lacks the Plant Homeodomain and Regulates Epithelial-Mesenchymal Transition in Prostate Cancer Cells.
    Melekhova A; Leeder M; Pungsrinont T; Schmäche T; Kallenbach J; Ehsani M; Mirzakhani K; Rasa SMM; Neri F; Baniahmad A
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COUP-TFII inhibits TGF-β-induced growth barrier to promote prostate tumorigenesis.
    Qin J; Wu SP; Creighton CJ; Dai F; Xie X; Cheng CM; Frolov A; Ayala G; Lin X; Feng XH; Ittmann MM; Tsai SJ; Tsai MJ; Tsai SY
    Nature; 2013 Jan; 493(7431):236-40. PubMed ID: 23201680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Klf5 deletion promotes Pten deletion-initiated luminal-type mouse prostate tumors through multiple oncogenic signaling pathways.
    Xing C; Ci X; Sun X; Fu X; Zhang Z; Dong EN; Hao ZZ; Dong JT
    Neoplasia; 2014 Nov; 16(11):883-99. PubMed ID: 25425963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer.
    Cohen B; Shimizu M; Izrailit J; Ng NF; Buchman Y; Pan JG; Dering J; Reedijk M
    Breast Cancer Res Treat; 2010 Aug; 123(1):113-24. PubMed ID: 19915977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.